Woven Orthopedic Technologies
Manchester, US · Delaware LLC
Founders & leadership
SW
Steve WardChief Financial Officer
AN
Anan NatarajanVice President of Commercialization
TC
Terrance CarlsonGeneral Counsel
RL
Robert LuzziVice President of R&D
FP
Francis P Magee, DVMChief Technology Officer
BB

Brandon BendesinVice President of Strategy and Finance
DH
David Helfet, MDChief Medical Officer
IO
Ilana OdessChief Executive Officer
Board
AG
Anthony G. ViscogliosiBoard director
PG
Pascal GirinBoard director
JD
J. Douglas CraftBoard director
FC
Frank Camissa, Jr, MDBoard director
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 3 of 4 rounds · 2013–2021
▶$10.7MraisedJul 2021 · 56 investors · Other Health CareRule 506(b)
▶$10.7MraisedJul 2021 · 56 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John MoranDirector
- Brandon BendesExecutive Officer
- Frank Cammisa, Jr., MDDirector
- J Douglas CraftDirector
- Anthony ViscogliosiDirector
- Andrew RockExecutive Officer, Director
- David Helfet, MDExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $10.7M
- Minimum investment
- $1K
- Finders' fees
- $8.3K
- Proceeds to insiders
- $200K
- Placement agents
- Timothy Dowling
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.8MraisedJan 2017 · 40 investors · Other Health CareRule 506(b)
▶$2.8MraisedJan 2017 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John ViscogliosiDirector
- Pascal GirinDirector
- David Helfet, MDExecutive Officer, Director
- J Douglas CraftDirector
- Frank Cammisa, Jr., MDDirector
- Anthony ViscogliosiDirector
- Terrance CarlsonExecutive Officer
- Ilana OdessExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $10K
- Sales commissions
- $61K
- Proceeds to insiders
- $142K
- Placement agents
- ARETE Wealth Management, Viscogliosi & Company, LLC
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$8.6MraisedApr 2016 · 59 investors · Other Health CareRule 506(b)
▶$8.6MraisedApr 2016 · 59 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Pascal GirinDirector
- Steve WardExecutive Officer
- Anan NatarajanExecutive Officer
- J. Douglas CraftDirector
- Terrance CarlsonExecutive Officer
- Anthony G. ViscogliosiDirector
- Robert LuzziExecutive Officer
- Francis P Magee, DVMExecutive Officer
- Brandon BendesExecutive Officer
- Frank Camissa, Jr, MDDirector
- David Helfet, MDExecutive Officer, Director
- Ilana OdessExecutive Officer, Director
- John J. ViscogliosiDirector
- Offering amount
- $8.6M
- Amount sold
- $8.6M
- Minimum investment
- $25K
- Sales commissions
- $302.4K
- Proceeds to insiders
- $2.4M
- Placement agents
- Viscogliosi & Company, LLC
- First sale
- Dec 2013
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Woven Orthopedic Technologies raised?
- Woven Orthopedic Technologies has disclosed $22.1M raised across 3 of its 4 known rounds.
- Where is Woven Orthopedic Technologies headquartered?
- Woven Orthopedic Technologies is headquartered in Manchester, US.